September 5, 2017 - By Michael Collier

Shares of Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) closed at 6.12 yesterday. Shenzhen Neptunus Bioengineering Co. Ltd currently has a total float of shares and on average sees shares exchange hands each day. The stock now has a 52-week low of 5.29 and high of 7.78.

Amid numerous setbacks in the past, China has still proven itself to have one of the most important economies not just in Asia but in the whole world. Trade and commerce is richly flourishing in the nation and the Shanghai Stock Exchange (SSE) is one of the reasons it does. It is also the best place to show full potential for Shenzhen Neptunus Bioengineering Co. Ltd and its colleagues.

The SSE, one of Chinas primary stock exchanges aside from the Shenzhen Stock Exchange, is a non-profit organization that is administered by the China Securities Regulatory Commission (CSRC). As of February, the SSE boasts with a market capitalization of $3.50 trillion, making it the fifth largest stock exchange in the world. In Asia, it is the second biggest stock exchange. The second biggest market in the world increased the chances of Shenzhen Neptunus Bioengineering Co. Ltd to catch attention of investors.

The SSE was established in 1866 but it had to close on December 5, 1941 when Japan invaded Shanghai. Operations did not resume until December 19, 1990.

Shortly after the relaunch of the SSE, the SSE Composite Index began operating on July 15, 1991 as the primary index measuring all stocks on the SSE based on market capitalization. It tracks companies using the Paasche weighted composite price index formula. Measuring more than 1,000 companies listed on the SSE means that the SSE Composite Index is a broad indicator of the Chinese economy. As a result, it had to have three sub-indices: 1) the SSE 380, which monitors the 380 most active companies; 2) the SSE 180, which monitors the 180 most active companies; and 3) the SSE 50, which monitors the 50 most active companies. Of course, in order to be included in the SSE 50, a company needs to first be included in the SSE 180 and the SSE 380. Similarly, in order for it to be included in the SSE 180, it first needs to be included in the SSE 380. The smaller the index, the clearer of a representation it is of the Chinese economy.

The SSE Composite Index has last seen its all-time high of 6,092.06 in October 2007, shortly before the 2008 Global Financial Crisis broke out; and its all-time low of 99.98 in December 1990 during the relaunch period of the SSE.

Companies listed on the SSE are classified into two types: 1) A shares, which are traded in yuan; and 2) B shares, which are traded in US dollar (USD). In the past, only domestic traders had been allowed to trade A shares. Foreign investors had been limited to B shares. However, the restriction was lifted in 2002, giving the Chinese economy more opportunities to grow immensely with greater foreign investments. It means more possibilities for Shenzhen Neptunus Bioengineering Co. Ltd.

The regular trading session on the SSE starts at 9:30 and ends at 11:30 in the morning and starts at 1:30 and ends at 3:00 in the afternoon. There is also a pre-market trading session that starts at 9:15 a.m. and lasts for 10 minutes.

China is Asias largest economy, which is why there is no better way to bet on the Asian trade and commerce environment than to invest on SSE stocks. Traders look on the liquidity of Shenzhen Neptunus Bioengineering Co. Ltd.

More important recent Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) news were published by: Businesswire.com which released: Provision Asia and Shenzhen Hairong International Medical Development Form on June 03, 2016, also Businesswire.com published article titled: Research and Markets: Report on Health Food Industry in China 2015-2019, Marketwatch.com published: 20.05 on May 20, 2011. More interesting news about Shenzhen Neptunus Bioengineering Co. Ltd (SHE:000078) was released by: Marketwatch.com and their article: 24.59 with publication date: March 10, 2011.

Shenzhen Neptunus Bioengineering Co.,Ltd is a China firm principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The company has market cap of $. The Companys main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. It currently has negative earnings.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Michael Collier

Link:
Shenzhen Neptunus Bioengineering Co. Ltd (000078) Is Yet to See Trading Action on Sep 5 - MoneyMakingArticles